Abstract
Seventeen subjects with chronic severe asthma completed a 48 week prospective, double blind study with crossover of treatment at 24 weeks, in which triamcinolone acetonide 80 mg intramuscularly every four weeks was compared with oral prednisolone 10 mg daily. Spirometry, twice daily measurements of peak expiratory flow rate, and self assessment of asthma symptom scores showed significant improvement during triamcinolone treatment; less extra prednisolone was required and there was significant weight loss. Two patients withdrew, one because of dissatisfaction with prednisolone and one because of side effects while taking triamcinolone. Three were withdrawn, one with proximal muscle weakness and two because of intercurrent illness. Adrenal suppression, bruising, and hirsuitism were worse with triamcinolone, other side effects being comparable. On completion of the study 16 of the 17 patients opted to continue taking triamcinolone acetonide. This treatment is an important addition to the therapeutic options available for chronic severe asthma.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arnold H. L., Jr Safer long-term steroid therapy with injected triamcinolone acetonide. Int J Dermatol. 1978 Apr;17(3):216–217. doi: 10.1111/j.1365-4362.1978.tb06063.x. [DOI] [PubMed] [Google Scholar]
- Carmichael J., Paterson I. C., Diaz P., Crompton G. K., Kay A. B., Grant I. W. Corticosteroid resistance in chronic asthma. Br Med J (Clin Res Ed) 1981 May 2;282(6274):1419–1422. doi: 10.1136/bmj.282.6274.1419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carson T. E., Daane T. A., Weinstein R. L. Long-term intramuscular administration of triamcinolone acetonide. Effect on the hypothalamic-pituitary-adrenal axis. Arch Dermatol. 1975 Dec;111(12):1585–1587. [PubMed] [Google Scholar]
- Droszcz W., Lech B., Malunowicz E., Piotrowska B. Factors influencing adrenocortical suppression during long-term triamcinolone acetonide therapy in asthma. Ann Allergy. 1980 Mar;44(3):174–176. [PubMed] [Google Scholar]
- Flower R. J., Blackwell G. J. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature. 1979 Mar 29;278(5703):456–459. doi: 10.1038/278456a0. [DOI] [PubMed] [Google Scholar]
- Keogh B. A., Bernardo J., Hunninghake G. W., Line B. R., Price D. L., Crystal R. G. Effect of intermittent high dose parenteral corticosteroids on the alveolitis of idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1983 Jan;127(1):18–22. doi: 10.1164/arrd.1983.127.1.18. [DOI] [PubMed] [Google Scholar]
- Kusama M., Sakauchi N., Kumaoka S. Studies of plasma levels and urinary excretion after intramuscular injection of triamcinolone acetonide. Metabolism. 1971 Jun;20(6):590–596. doi: 10.1016/0026-0495(71)90007-2. [DOI] [PubMed] [Google Scholar]
- Mikhail G. R., Sweet L. C., Mellinger R. C. Parenteral long-acting corticosteroids: effect on hypothalamic-pituitary-adrenal function. Ann Allergy. 1973 Jul;31(7):337–343. [PubMed] [Google Scholar]
- Nash J., Jacomb R. G. Corticosteroid therapy in chronic asthma. Practitioner. 1968 Aug;201(202):358–361. [PubMed] [Google Scholar]
- Peake M. D., Cayton R. M., Howard P. Triamcinolone in corticosteroid-resistant asthma. Br J Dis Chest. 1979 Jan;73(1):39–44. [PubMed] [Google Scholar]
- Walsh S. D., Grant I. W. Corticosteroids in treatment of chronic asthma. Br Med J. 1966 Oct 1;2(5517):796–802. doi: 10.1136/bmj.2.5517.796. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Willey R. F., Fergusson R. J., Godden D. J., Crompton G. K., Grant I. W. Comparison of oral prednisolone and intramuscular depot triamcinolone in patients with severe chronic asthma. Thorax. 1984 May;39(5):340–344. doi: 10.1136/thx.39.5.340. [DOI] [PMC free article] [PubMed] [Google Scholar]